Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Merck
MRK
|
$468M |
| 2 |
Johnson & Johnson
JNJ
|
$458M |
| 3 |
Booking.com
BKNG
|
$358M |
| 4 |
IBM
IBM
|
$352M |
| 5 |
RAI
Reynolds American Inc
RAI
|
$347M |
Top Sells
| 1 |
LLTC
Linear Technology Corp
LLTC
|
$482M |
| 2 |
Walt Disney
DIS
|
$255M |
| 3 |
Visa
V
|
$226M |
| 4 |
Deere & Co
DE
|
$201M |
| 5 |
Johnson Controls International
JCI
|
$179M |
Sector Composition
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.41% |
| 3 | Financials | 12.25% |
| 4 | Consumer Staples | 9.57% |
| 5 | Industrials | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$427B
| $885M | 1.24% | 7,102,700 +3,679,600 | +107% | +$458M |
|
2
NetEase
NTES
$86.2B
| $645M | 0.9% | 2,269,700 +255,800 | +13% | +$72.6M |
|
3
Mastercard
MA
$538B
| $591M | 0.83% | 5,252,700 -388,700 | -7% | -$43.7M |
|
4
Novo Nordisk
NVO
$251B
| $563M | 0.79% | 16,409,200 +2,463,300 | +18% | +$84.4M |
|
5
Humana
HUM
$36.5B
| $555M | 0.78% | 2,691,700 +1,231,400 | +84% | +$254M |
|
6
Gilead Sciences
GILD
$140B
| $523M | 0.73% | 7,707,248 +2,432,300 | +46% | +$165M |
|
7
Colgate-Palmolive
CL
$67.9B
| $501M | 0.7% | 6,849,600 -1,604,000 | -19% | -$117M |
|
8
PepsiCo
PEP
$204B
| $486M | 0.68% | 4,343,800 +2,067,338 | +91% | +$231M |
|
|
9
Merck
MRK
$210B
| $468M | 0.65% | +7,363,034 | New | +$468M |
|
10
NVIDIA
NVDA
$4.24T
| $435M | 0.61% | 3,990,593 +895,893 | +29% | +$97.6M |
|
|
AET
11
DELISTED
Aetna Inc
AET
| $397M | 0.55% | 3,111,482 +268,700 | +9% | +$34.3M |
|
12
Amgen
AMGN
$155B
| $396M | 0.55% | 2,413,445 +634,800 | +36% | +$104M |
|
13
Domino's
DPZ
$15.6B
| $393M | 0.55% | 2,130,700 +517,200 | +32% | +$95.3M |
|
14
Crown Castle
CCI
$43.2B
| $378M | 0.53% | 3,998,603 +1,043,700 | +35% | +$98.6M |
|
15
Walmart
WMT
$774B
| $364M | 0.51% | 5,043,400 +1,084,300 | +27% | +$78.2M |
|
16
Cboe Global Markets
CBOE
$24.7B
| $362M | 0.51% | 4,467,300 +81,200 | +2% | +$6.58M |
|
|
17
Booking.com
BKNG
$181B
| $358M | 0.5% | +201,199 | New | +$358M |
|
18
VeriSign
VRSN
$25.5B
| $358M | 0.5% | 4,104,376 -159,000 | -4% | -$13.9M |
|
|
19
IBM
IBM
$227B
| $352M | 0.49% | +2,023,700 | New | +$352M |
|
20
Bristol-Myers Squibb
BMY
$96B
| $352M | 0.49% | 6,468,000 +5,871,000 | +983% | +$319M |
|
|
RAI
21
DELISTED
Reynolds American Inc
RAI
| $348M | 0.49% | 5,514,535 +5,503,235 | +48,701% | +$347M |
|
22
Costco
COST
$418B
| $317M | 0.44% | 1,891,800 -927,913 | -33% | -$156M |
|
23
Meta Platforms (Facebook)
META
$1.86T
| $313M | 0.44% | 2,201,800 +2,141,800 | +3,570% | +$304M |
|
24
Sherwin-Williams
SHW
$91.2B
| $298M | 0.42% | 961,900 +635,900 | +195% | +$197M |
|
25
American Electric Power
AEP
$59.4B
| $294M | 0.41% | 4,383,800 +496,200 | +13% | +$33.3M |
|